Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...

A sexual predator who plied six women with drugs and alcohol before raping them has been jailed. Shane James Gibbs, 35, was a ...

Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...

Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.

The Kenya Medical Supplies Authority (KEMSA) on Friday released antiretroviral drugs (ARVs) to reach over 1 million Kenyans.

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

HIV commodities worth about Sh30 billion are lying at the Mombasa Road warehouses of the Mission for Essential Drugs & Supplies (MEDS), awaiting distribution, the NSDCC has said.The consignment ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...